Nektar Therapeutics | Passività Correnti



Current Liabilities Cambiamento Data
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
ALKERMES USD 443.73M 21.47M 2025-03
Amgen USD 23.01B 91M 2025-03
Baxter International USD 6.51B 311M 2024-12
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Cipla INR 54.84B 291.6M 2025-03
Dr.Reddys Laboratories INR 130.34B 1.61B 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Grifols EUR 2.16B 199.43M 2024-12
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 25.17B 3.25B 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Takeda JPY 2.51T 408.56B 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Xencor USD 88.44M 1M 2025-03



Nektar Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.